The Risk of Sudden Death in Children with Hypertrophic Cardiomyopathy

Area of Science:

• Pediatric Cardiology
• Cardiovascular Genetics
• Sudden Cardiac Death Research

Background:

• Sudden cardiac death (SCD) is the leading cause of mortality in pediatric patients with hypertrophic cardiomyopathy (HCM).
• Current risk stratification for SCD in childhood HCM relies on adult-derived models with limited accuracy.
• There is a critical need for pediatric-specific strategies to guide interventions like implantable cardioverter defibrillator (ICD) implantation.

Purpose of the Study:

• To review the pathophysiology and risk factors associated with SCD in childhood HCM.
• To discuss the limitations of current risk stratification methods extrapolated from adult populations.
• To introduce novel, pediatric-specific risk models for personalized decision-making regarding ICD implantation.

Main Methods:

• Review of existing literature on childhood HCM, SCD, and risk stratification.
• Analysis of differences between pediatric and adult HCM cohorts regarding SCD risk.
• Description of newly developed pediatric risk prediction models for SCD.

Main Results:

• Childhood HCM exhibits distinct SCD patterns compared to adult HCM, necessitating tailored approaches.
• Traditional risk factor thresholds show poor discriminatory ability in pediatric populations.
• Newer pediatric models enable individualized 5-year SCD risk estimation, facilitating personalized ICD implantation decisions.

Conclusions:

• Pediatric-specific risk stratification is essential for managing SCD risk in childhood HCM.
• Personalized risk assessment using novel models improves decision-making for ICD implantation in children.
• Further research is needed to address remaining questions in pediatric HCM SCD risk stratification.